Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin-changing study intending to gain patients' insights into insulin treatment with patient-reported health outcomes in actual clinical treatments (INSIGHTs) study

Journal of Diabetes Investigation

Volumn 4, Issue 6, 2013, Pages 560-570

  Ishii, Hitoshi ^a   Terauchi, Yasuo ^b   Jinnouchi, Hideaki ^c   Taketsuna, Masanori ^d   Takeuchi, Masakazu ^d   Imaoka, Takeshi ^d  

^a TENRI HOSPITAL   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Jinnouchi Hospital   (Japan)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Glycated hemoglobin; Insulin therapy related quality of life questionnaire; Type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; BIPHASIC INSULIN; BIPHASIC INSULIN ANALOG; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; INTERMEDIATE ACTING INSULIN; INTERMEDIATE ACTING INSULIN ANALOG; LONG ACTING INSULIN; LONG ACTING INSULIN ANALOG; ORAL ANTIDIABETIC AGENT; SHORT ACTING INSULIN; SULFONYLUREA; ULTRA RAPID ACTING INSULIN ANALOG; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BEDTIME DOSAGE; DAILY LIFE ACTIVITY; DEVICES; DIABETES TREATMENT SATISFACTION QUESTIONNAIRE; EVENING DOSAGE; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INJECTION; INSULIN THERAPY RELATED QUESTIONNAIRE; INSULIN TREATMENT; JAPANESE; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; TREATMENT OUTCOME;

EID: 84888438825     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12086     Document Type: Article

References (30)

1. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
2. Shichiri M, Kishikawa H, Ohkubo Y, et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000; 23(Suppl. 2): B21-B29.
3. Holman RR, Paul SK, Bethel MA, et al. 10-Year follow-up of intensive glucose control in type 2 diabetes. New Engl J Med 2008; 359: 1577-1589.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
5. Pouwer F, Hermanns N. Insulin therapy and quality of life. A review. Diabetes Metab Res Rev 2009; 25(Suppl. 1): S4-S10.
6. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev 1999; 15: 205-218.
7. Zhang X, Norris SL, Chowdhury FM, et al. The effects of interventions on health-related quality of life among persons with diabetes: a systematic review. Med Care 2007; 45: 820-834.
8. Vijan S, Hayward R, Ronis D, et al. Brief report: the burden of diabetes therapy. J Gen Intern Med 2005; 20: 479-482.
9. Bradley C, Gilbride CJ. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine. Diabetes Obes Metab 2008; 10(Suppl. 2): 50-65.
10. Bradley C, Plowright R, Stewart J, et al. The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ. Health Qual Life Outcomes 2007; 5: 57.
11. Bretzel RG, Nuber U, Landgraf W, et al. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial. Lancet 2008; 371: 1073-1084.
12. Horvath K, Jeitler K, Berghold A, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007; (2): CD005613.
13. Plank J, Siebenhofer A, Berghold A, et al. Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus. Arch Intern Med 2005; 165: 1337-1344.
14. Siebenhofer A, Plank J, Berghold A, et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2006; (2): CD003287.
15. Ishii H, Iwase M, Seino H, et al. Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan. Curr Med Res Opin 2011; 27: 643-650.
16. Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28: 1568-1573.
17. Ishii H, Anderson JH Jr, Yamamura A, et al. Improvement of glycemic control and quality-of-life by insulin lispro therapy: assessing benefits by ITR-QOL questionnaires. Diabetes Res Clin Pract 2008; 81: 169-178.
18. Ishii H, Yamamoto T, Ohashi Y. Development of insulin therapy related quality-of-life measure (ITR-QOL). J Jpn Diabetes Soc 2001; 44: 9-15 (Japanese).
19. Japan Pharmaceutical Manufacturers Association. Post-marketing Surveillance of Drugs. Pharmaceutical Administration and Regulations in Japan. (Cited March 2012). Available at URL: http://www.jpma.or.jp/english/parj/1203.html.
20. Seino Y, Nanjo K, Tajima N, et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Invest 2010; 1: 212-228.
21. Kashiwagi A, Kasuga M, Araki E, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012; 3: 39-40.
22. Bradley C. The diabetes treatment satisfaction questionnaire: DTSQ. In: Bradley C (ed). Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Harwood Academic Publishers, Chur, Switzerland, 1994; 111-132.
23. Ishii H, Bradley C, Riazi A, et al. The Japanese version of the Diabetes Treatment Satisfaction Questionnaire (DTSQ): translation and clinical evaluation. J Clin Exp Med 2000; 192: 809-814 (Japanese).
24. Kobayashi M, Yamazaki K, Hirao K, et al. The status of diabetes control and antidiabetic drug therapy in Japan-A cross-sectional survey of 17, 000 patients with diabetes mellitus (JDDM 1). Diabetes Res Clin Pract 2006; 73: 198-204.
25. Kunt T, Snoek FJ. Barriers to insulin initiation and intensification and how to overcome them. Int J Clin Pract 2009; 63: 6-10.
26. Jenkins N, Hallowell N, Farmer AJ, et al. Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study. Diabet Med 2011; 28: 543-548.
27. Delamater AM. Improving patient adherence. Clin. Diabetes 2006; 24: 71-77.
28. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193-203.
29. Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract 2004; 66: S37-S43.
30. Wang JS, Tu ST, Lee IT, et al. Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring. Diabetes Metab Res Rev 2011; 27: 79-84.